Bioceres reported 1Q26 results with continued revenue declines but improved gross margins and significant OpEx reductions, boosting profitability. BIOX faces severe financial risks, including default claims and lawsuits to accelerate over $100 million in debt, which it cannot cover with current cash. Equity holders face high dilution risk from convertible notes and potential asset sales, as the company cannot be evaluated as a going concern.
Bioceres Crop Solutions Corp. ( BIOX ) Q1 2026 Earnings Call November 13, 2025 8:30 AM EST Company Participants Paula Savanti - Head of Investor Relations Federico Trucco - Executive Chairman & CEO Conference Call Participants Austin Moeller - Canaccord Genuity Corp., Research Division Presentation Operator Good morning all, and thank you for joining us on today's Bioceres Crop Solutions Fiscal First Quarter 2026 Financial and Operational Results. My name is Drew, and I'll be the operator on the call today.
Bioceres Crop (BIOX) came out with a quarterly loss of $0.12 per share versus the Zacks Consensus Estimate of a loss of $0.04. This compares to a loss of $0.09 per share a year ago.
| Biotechnology Industry | Healthcare Sector | Federico Trucco CEO | XSTU Exchange | KYG1117K1141 ISIN |
| AR Country | 400 Employees | - Last Dividend | - Last Split | 22 Mar 2018 IPO Date |
Bioceres Crop Solutions Corp., founded in 2001 and based in Rosario, Argentina, specializes in offering comprehensive crop productivity solutions globally. The company, through its various subsidiaries, operates across diverse segments including Seed and Integrated Products, Crop Protection, and Crop Nutrition. Bioceres aims to enhance agricultural output by providing innovative solutions that promote healthier and higher yielding crops. Its operations are widespread, spanning countries such as Argentina, Bolivia, Brazil, Colombia, Estonia, the United States, Paraguay, Russia, South Africa, France, Uruguay, and other international locations. With a focus on sustainability and efficiency, Bioceres Crop Solutions Corp. leverages cutting-edge technology to address the challenges faced by modern agriculture.
The offerings of Bioceres Crop Solutions Corp. are vast and are grouped into three primary segments, each focusing on a different aspect of crop production enhancement.
This segment delivers a suite of products aimed at boosting crop health and yield through advanced seed technology. Key offerings include:
Bioceres provides a wide range of products designed to protect crops from pests, diseases, and other stress factors. Offerings include:
To support the growth and health of crops, Bioceres offers a range of nutritional products, including:
In addition to these segment-specific products, Bioceres is also known for its HB4 technology, a groundbreaking drought-tolerant seed technology program, exemplifying the company's commitment to developing sustainable agricultural practices.